Longitudinal CA125 detection of sporadic papillary serous carcinoma of the peritoneum

被引:15
|
作者
Skates, S
Troiano, R
Knapp, RC
机构
[1] Massachusetts Gen Hosp, MGH Biostat Ctr, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Cornell Univ, Weill Med Coll, Dept Obstet & Gynecol, New York, NY USA
[4] Cornell Univ, Weill Med Coll, Dept Radiol, New York, NY USA
关键词
longitudinal CA125; papillary serous carcinoma of the peritoneum;
D O I
10.1046/j.1525-1438.2003.t01-1-13050.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this case, rising longitudinal levels of CA125 were significant in the detection of peritoneal papillary serous carcinoma, and led to the indication for surgery. Rising longitudinal CA125 has been shown to be important in the detection of ovarian cancer, but little data exist as to its relevance for the detection of peritoneal papillary serous carcinoma. This rare primary tumor is usually associated with women at high risk for epithelial ovarian carcinoma, although this patient was not at high risk as she had no familial breast or ovarian cancer history.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 50 条
  • [31] Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma
    Abramovich, D
    Markman, M
    Kennedy, A
    Webster, K
    Belinson, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (12) : 697 - 698
  • [32] Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma
    Drew Abramovich
    Maurie Markman
    Alexander Kennedy
    Kenneth Webster
    Jerome Belinson
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 697 - 698
  • [33] CA125 production by the peritoneum: in-vitro and in-vivo studies
    Epiney, M
    Bertossa, C
    Weil, A
    Campana, A
    Bischof, P
    HUMAN REPRODUCTION, 2000, 15 (06) : 1261 - 1265
  • [34] Computed tomography findings of primary serous papillary carcinoma of the peritoneum in women
    Kebapci, M
    Yalcin, OT
    Dündar, E
    Ozalp, SS
    Kaya, T
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (06) : 552 - 556
  • [35] ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum
    Garrett, AP
    Ng, SW
    Muto, MG
    Welch, WR
    Bell, DA
    Berkowitz, RS
    Mok, SC
    GYNECOLOGIC ONCOLOGY, 2000, 77 (01) : 105 - 111
  • [36] Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma
    Kakimoto, Soichiro
    Miyamoto, Morikazu
    Einama, Takahiro
    Matsuura, Hiroko
    Iwahashi, Hideki
    Ishibashi, Hiroki
    Sakamoto, Takahiro
    Hada, Taira
    Takano, Masashi
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2299 - 2306
  • [37] Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation
    Chopra, S
    Laurie, LR
    Chintapalli, KN
    Valente, PT
    Dodd, GD
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2000, 24 (03) : 395 - 399
  • [38] A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer
    Salminen, Liina
    Nadeem, Nimrah
    Jain, Shruti
    Grenman, Seija
    Carpen, Olli
    Hietanen, Sakari
    Oksa, Sinikka
    Lamminmaki, Urpo
    Pettersson, Kim
    Gidwani, Kamlesh
    Huhtinen, Kaisa
    Hynninen, Johanna
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 689 - 694
  • [39] Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer
    Simmons, Archana R.
    Fourkala, Evangelia Ourania
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Sutton, Margie N.
    Baggerly, Keith
    Zheng, Hui
    Lu, Karen H.
    Jacobs, Ian
    Skates, Steven
    Menon, Usha
    Bast, Robert C., Jr.
    CANCER PREVENTION RESEARCH, 2019, 12 (06) : 391 - 399
  • [40] CA-125 LEVELS ARE SIGNIFICANTLY ASSOCIATED WITH PROGNOSTIC PARAMETERS IN UTERINE PAPILLARY SEROUS CARCINOMA
    Shmidt, M.
    Segev, Y.
    Auslender, R.
    Sade, R.
    Feferkorn, I.
    Kaldawy, A.
    Kligun, G.
    Lavie, O.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1141 - 1141